• SENSEX 77,250.10
    332.25 (+0.43%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,824.90 1,878.00(%)
  • Bharti Airtel
    2,042.90 1,726.05(%)
  • Reliance Industries
    1,315.50 1,611.20(%)
  • SBI Life Insuran
    1,706.80 2,132.90(%)
  • Saregama India
    647.20 574.85(%)
  • Multi Comm. Exc.
    3,252.50 1,761.43(%)
  • Aster DM Quality
    710.25 890.95(%)
  • Shree Cement
    24,342.85 28,306.45(%)
  • Jio Platforms
    1,420.50 1,356.40(%)
  • SFC Enviro.
    397.60 354.05(%)
  • Global Health
    1,422.10 1,542.00(%)
  • HDFC Bank
    741.00 1,017.90(%)
  • BLS Polymers
    261.80 225.00(%)
  • J K Cements
    5,155.30 6,363.00(%)
  • Info Edg.(India)
    1,159.40 909.20(%)
  • ITC
    283.50 421.70(%)
  • SBI
    987.75 1,234.80(%)
  • M & M
    2,942.00 3,840.00(%)
  • TBO Tek
    1,522.00 1,005.50(%)
  • Fractal Analyt.
    839.45 1,119.60(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Concord Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 72610.0
  • ISIN : INE338H01029
613.95 32 (5.54%)
  • As on 04 Nov 2026 (EOD)

  • Today’s Low

    583.50

  • Today’s High

    624.00

  • Open

    586.50

  • Perv Close

    581.75

  • 52W Low

    493.50

  • 52W High

    807.50

Key Indicators

  • P/E(TTM)

    43.29

  • Mar.Cap (₹Cr.)

    12,845.82

  • Div & Yield %

    0.61

  • Book Value(₹)

    199.42

  • Debt-Equity Ratio

    5.54

  • AGM Date

    03-Nov-2026

  • EPS

    28.41

  • P/E Ratio

    43.29

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    12,845.82

  • RONW (%)

    21.88

  • ROCE (%)

    29.05

Score Board

  • Equity (₹ in Cr.)

    10.46

  • BV (₹)

    199.40

  • Sales( ₹ in Cr.)

    1,055.07

  • NP (in Cr.)

    240.92

  • NP Var(%)

    -30.0

  • Div%

    755.0

  • CPS (₹)

    30.10

  • EPS (₹)

    23.00

  • Traded Value (₹ in Lakhs)

    12,866.22

  • 52 Week High

    807.50

  • 52 Week Low

    493.50

  • Price BSE

    1230.0

  • Price NSE

    1,228.00

  • Market Capital( in Cr.)

    12,866.22

  • P/C Ratio

    40.80

  • P/E Ratio

    53.40

  • Price Vs.BV

    23.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,055.07 1,200.09 1,016.94 853.17 712.93 616.94
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,055.07 1,200.09 1,016.94 853.17 712.93 616.94
Other Income 52.73 44.45 33.78 35.31 23.42 13.81
Stock Adjustments 70.61 14.79 12.08 15.63 23.98 39.05
Total Income 1,178.41 1,259.33 1,062.80 904.11 760.33 669.80
EXPENDITURE :            
Raw Materials 316.58 320.30 241.28 195.84 187.99 150.61
Power and Fuel Cost 116.20 112.23 104.97 97.65 71.64 39.86
Employee Cost 170.19 138.93 123.05 110.28 95.69 69.47
Other Manufacturing Expenses 30.77 26.18 28.00 24.93 17.10 12.99
Selling and Administration Expenses 100.88 99.31 91.08 82.93 67.90 44.87
Miscellaneous Expenses 17.28 11.09 8.46 13.20 22.66 10.26
Employee Benefit Expenses 170.19 138.93 123.05 110.28 95.69 69.47
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 751.89 708.03 596.83 524.84 462.99 328.05
Operating Profit 426.53 551.29 465.97 379.27 297.34 341.74
Interest 0.77 1.04 3.18 5.18 6.13 1.05
Gross Profit 425.76 550.25 462.79 374.09 291.21 340.69
Depreciation 74.33 54.37 53.59 54.03 50.05 27.52
Profit Before Tax 351.43 495.88 409.20 320.06 241.16 313.17
Current Tax 86.29 118.96 99.83 79.53 58.49 75.72
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.87 3.95 4.63 2.40 4.10 2.11
Reported Net Profit 263.27 372.96 304.73 238.13 178.57 235.33
Extraordinary Items 22.35 27.50 10.48 2.70 3.86 5.24
Adjusted Net Profit 240.92 345.46 294.25 235.43 174.71 230.09
Adjustment below Net Profit 55.78 5.97 -0.01 0.26 -0.56 -0.04
P & L Balance brought forward 1,691.00 1,403.60 1,170.33 985.51 878.02 648.43
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 111.94 91.54 71.45 53.56 70.52 5.71
P & L Balance carried down 1,898.10 1,691.00 1,403.60 1,170.33 985.51 878.02
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 755.00 875.00 875.00 683.00 51.20 0.00
Dividend Per Share(Rs) 7.55 10.70 8.75 6.83 5.12 0.00
Earnings Per Share-Unit Curr 25.17 35.65 29.13 22.76 187.76 247.44
Earnings Per Share(Adj)-Unit Curr 25.17 35.65 29.13 - - -
Book Value 193.06 173.27 145.80 123.50 1,164.13 1,051.11
Book Value(Adj)-Unit Curr 193.06 173.27 145.80 - - -

Shareholding Pattern

  • Promoter Group

    44.09%

  • Public Share Holding

    55.91%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,752,000 4.54 4,752,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 5,500 0.01 5,500 1
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 41,364,608 39.54 41,364,608 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 46,122,108 44.09 46,122,108 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,612,438 7.28 7,612,438 107
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,456,578 4.26 4,456,578 6
Mutual Funds / UTI 6,110,096 5.84 6,110,096 22
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 890,704 0.85 890,704 10
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 19,069,816 18.23 19,069,816 145
2] Non Institution
Bodies Corporate 2,372,833 2.27 2,372,833 444
Clearing Members 1,022,364 0.98 1,022,364 20
Directors of their Relatives 340,482 0.33 340,482 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 924,072 0.88 924,072 1,919
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 264,933 0.25 264,933 2,631
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,256,432 1.20 1,256,432 1
Individuals holding nominal share capital up to Rs. 1 lakh 7,963,329 7.61 7,963,329 83,137
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 25,203,217 24.09 25,203,217 4
Others 0 0.00 0 0
Sub Total 39,424,280 37.68 39,424,280 88,213
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 104,616,204 100.00 104,616,204 88,365

Company Background

Concord Biotech LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Concord Biotech Ltd
  • BSE Code : 72610.0
  • ISIN : INE338H01029

  • Incorporation Year

    1984

  • Registered Office

    1482-86 Trasad Road
    Dholka, Ahmedabad,
    Gujarat-382225

  • Telephone

    91-079-68138700

  • FAX

  • Chairman

    SUDHIR JAIRAM VAID

  • Managing Director

    SUDHIR JAIRAM VAID

  • Company Secretary

    Paritosh Trivedi

  • Auditor

    BSR & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Concord Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Concord Biotech 1,229.85 1,107.80 1,055.07 43.66 18.33
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77